Chronic obstructive pulmonary disease (COPD) is among the most common breathing conditions. It's the result of damaged lung ...

For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporte ...

Study objectives: To identify the predictors of medication adherence in patients with COPD and contrast the health beliefs, experiences, and behaviors of COPD patients self-reporting good ...

Please provide your email address to receive an email when new articles are posted on . Invited patients had 32% of days covered for maintenance inhalers, whereas control patients had a smaller ...

The medication adherence report scale (MARS ... A nutrition guide for patients with COPD was included as an ethically acceptable incentive to encourage patient response. The study received ...

This finding highlights the potential benefits of these medications beyond glucose control, particularly for patients managing both T2D and COPD. Recent studies have suggested that SGLT-2is, GLP-1RAs, ...

Share on Pinterest GLP-1 and SGLT-2 drugs may be the best treatments for people with type 2 diabetes and COPD. Image credit: Visual Vic/Getty Images. Researchers estimate the number of people ...

"This may inform prescribing of glucose-lowering medications among patients with T2D and active COPD," making SGLT2 and GLP-1 drugs preferable over DPP-4 inhibitors for these patients, the group ...

This may inform prescribing of glucose-lowering medications among patients with type 2 diabetes and active COPD.